You are here

Dr. Gunn Funding Newsletter

Here are recently released NIH and other FOAs.   FOAs for junior or new investigators are shown in red.  Duke opportunities are shown in blue.   The list of all active NIH RFAs and PAs, respectively, sorted by institute, can be found at: and

Note: NIH FOAs now include information as to whether the FOA supports clinical trials.  Here, this is designated by the following abbreviations:
CTNO - Clinical Trial Not Allowed; CTR - Clinical Trial Required; CTO - Clinical Trial Optional

December 26, 2017


  • None

Requests for Applications

  • Regeneration Next Postdoctoral Fellowship: Call for applications (see hereDeadline: Jan. 31, 2018
  • Translating Duke Health Call for Proposals:
    Immunology (see here) Deadline: Jan. 15, 2018
    Cardiovascular Health (see here) Deadline: Jan. 5, 2018
    Children’s Health and Discovery (see here) Deadline: Feb. 2, 2018
  • Duke-Coulter Translational Partnership Grants (see here) Preliminary Proposal Deadline: Jan. 31, 2018
  • Duke Global Health Institute Global Mental Health Research RFP (see here) Deadline: Jan. 16, 2018
  • Duke University NCI T32 Postdoctoral Research Training in Surgical Oncology: RFA (see here) Deadline: April 15, 2018
  • REACH Equity Career Development Award (see here) Deadline: Feb. 1, 2018
  • Duke Incubation Fund (see here) Deadline: Jan. 8, 2018
  • Duke Center for REsearch to AdvanCe Healthcare Equity Career Development Award (see here) Deadline: Feb. 1, 2018
  • Duke Department of Population Health Sciences -- Dissemination and Implementation Science in Cardiovascular Outcomes NIH K12 Mentored Career Development and Research Program (see here) Deadline: December 31, 2017
  • Duke CTSI Population Health Improvement Awards Program (see here) Deadline: January 24, 2018
  • Duke Forge Request for Questions to leverage data and expertise at Duke to improve health (see here) Deadline: January 23, 2018
  • Funding for Medable Axon use from Duke Mobile App Gateway (seehere) Deadline: Jan. 31, 2018
  • Chancellor’s Discovery Program (see here) Deadline: Jan. 25, 2018
  • Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01 - CTNO) (RFA-AG-18-022) NIA, Application Date(s): March 28, 2018
  • Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01 - CTNO) (RFA-AG-18-025) NIA, Application Date(s): March 28, 2018
  • Improving Implementation of Seek, Test, Treat and Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01-CTR) (RFA-DA-18-017) NIDA, Application Date(s): April 13, 2018 and November 15, 2018
  • Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01- CTNO) (RFA-DA-18-023) NIDA, Application Date(s): April 17, 2018
  • Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01, R21- CTO) (RFA-DK-17-017) (RFA-DK-17-018) NIDDK, Application Date(s): March 20, 2018
  • Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44- CTNO) (RFA-DK-17-029) NIDDK, Application Date(s): March 21, 2018 
  • Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 CTNO) (RFA-DK-17-030) NIDDK, Application Date(s): March 21, 2018 
  • BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3, U44 - CTR) (RFA-NS-18-021) (RFA-NS-18-022) NINDS, NCCIH, NIA, NIAAA, NIBIB, NICHD, NIDA, NIMH, Application Date(s): Multiple 
  • BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 - CTR) (RFA-NS-18-023) NINDS, NCCIH, NIA, NIAAA, NIBIB, NICHD, NIDA, NIMH, Application Date(s): Multiple  
  • Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trials Not Allowed) (RFA-RM-17-025)The Common Fund, Application Date(s): March 2, 2018
  • Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trials Not Allowed) (RFA-RM-17-027) The Common Fund,Application Date(s): March 2, 2018
  • Microphysiological Systems Data Center U24 (CTNO) (RFA-TR-18-005)NCATS, Application Date(s): March 21, 2018
  • NextGen Tissue Chip Testing Centers: Validating Microphysiological Systems (U24 CTNO) (RFA-TR-18-006) NCATS, Application Date(s): March 21, 2018
  • St. Baldricks Childhood Cancer Research Foundation 
    Infrastructure Grants (see here) Deadline: July 13, 2018
    St. Baldrick's Fellows (see here) Deadline: August 31, 2018
    Career Development Award (see here) Duke Internal Deadline: January 10, 2018
    Research Grants (see here) Duke Internal Deadline: January 10, 2018
    Supportive Care Research Grants (see here) Duke Internal Deadline: January 11, 2018
  • CDC Understanding and Addressing the Disparity in Vaccination Coverage Among U.S. Adolescents Living in Rural Versus Urban Areas(see here) Duke Internal Deadline: January 8, 2018
  • Children’s Tumor Foundation Young Investigator Awards (see here) Deadline: January 8, 2018
  • Gerber Foundation Research Grants in Pediatric Health (see here) Deadline: May 15, 2018
  • North Carolina Albert Schweitzer Fellows Program (see here) Deadline: February 1, 2018
  • Massage Therapy Foundation Research Grants (see here) Deadline: March 1, 2018
  • Friedreichs Ataxia Research Alliance Grant Program (see here) Deadline: February 1, 2018
  • PCORI 
    Improving Methods for Conducting PCOR (see here
    Broad PCORI Funding Announcements (see here
    Dissemination and Implementation of PCORI-Funded Patient-Centered Outcomes Research Results (see here
    Deadline: February 13, 2018
  • American Society for Reproductive Medicine Research Grants (see here) Deadline: March 5, 2018 
  • Vertex Fellows Program (see here) Deadline: Jan. 31, 2018

Program Announcements

  • Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21, R01, R15 CTO) (PA-18-347) (PA-18-348) (PA-18-473) NIA, Application Date(s): Standard dates apply
  • Self-Management for Health in Chronic Conditions (R01, R21, R15CTO) (PA-18-376) (PA-18-384) (PA-18-474) NIA, Application Date(s): Standard dates apply
  • Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01, R21 - CTO) (PA-18-507) (PA-18-508) NIAAA, Application Date(s): Standard dates apply The first due date for this FOA is June 5, 2018
  • Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - CTNO) (PA-18-517) NCI, NCATS, NGRI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NIOSH, Application Date(s): March 5, 2018 
  • Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 CTNO) (PA-18-525) NIAID, Application Date(s): Standard dates apply
  • Early-life Factors and Cancer Development Later in Life (R01, R03, R21 - CTNO) (PA-18-529) (PA-18-531) (PA-18-532) NCI, Application Date(s): Standard dates apply .
  • Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - CTO) (PA-18-545) NIA, NCCIH, NCI, NICHD, NIDA, NINDS, Application Date(s): Standard dates apply
  • Advancing Basic Neurobiology Toward Translation Through Assay Development (R01 Clinical Trials Not Allowed) (PAR-18-505) NIMH, Application Date(s): Standard dates apply
  • Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - CTO) (PAR-18-506) NICHD, Application Date(s): Standard dates apply
  • Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21, R01, R03 CTO ) (PAR-18-509) (PAR-18-510) (PAR-18-527) NIDA, Application Date(s): Standard dates apply
  • Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 - CTO) (PAR-18-511) NICHD, Application Date(s): Standard dates apply
  • Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (R43/R44, R41/R42 CTNO) (PAR-18-512) (PAR-18-514) NIA,  Application Date(s): Standard dates apply 
  • Alzheimer's Clinical Trials Consortium Clinical Trials (R01 CTR) (PAR-18-513) NIA, Application Date(s):  Standard dates apply
  • Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 -CTNO) (PAR-18-516) NIA, Application Date(s): Multiple
  • Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - CTNO) (PAR-18-519) NIA, Application Date(s): Multiple  
  • NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 CTR) (PAR-18-521) Application Date(s): Standard dates apply
  • NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- CTR) (PAR-18-522) Application Date(s): Standard dates apply
  • NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-CTR)(PAR-18-523) Application Date(s): Standard dates apply
  • Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - CTNO) (PAR-18-524) NIA, Application Date(s): March 29, 2018, then standard dates apply
  • NeuroNEXT Clinical Trials (U01 - CTO) (PAR-18-528) NINDS, Application Date(s): Standard dates apply